00881nas a2200193   4500000000100000008004100001653001400042653001500056653002700071653001200098653001200110653001000122100001600132700001400148245010000162300001300262490000700275520040500282       1988                            d10aTreatment10aRifampicin10aPaucibacillary leprosy10aleprosy10aDapsone10aChina1 aWen-Zhong L1 aGan-Yun Y00a[Results of six-month treatment of paucibacillary leprosy patients with rifampicin and dapsone]  a355-357 0 v213 aThe effects of six months of treatment with rifampicin (RFP) and dapsone (DDS) recommended by WHO in 61 untreated paucibacillary leprosy patients are reported through 2 years follow-up. At the end of six months of treatment, 53 cases (86.9%) remained active with an inactivity index of 0.13, and at the time of 12 months of follow-up, 21 cases (34.3%) were active,with an inactivity index of 0.66.